Territory Stories

The Northern Territory news Thu 13 May 2010

Details:

Title

The Northern Territory news Thu 13 May 2010

Other title

NT news

Collection

The Northern Territory news; NewspaperNT

Date

2010-05-13

Description

This publication contains may contain links to external sites. These external sites may no longer be active.

Language

English

Subject

Community newspapers -- Northern Territory -- Darwin; Australian newspapers -- Northern Territory -- Darwin

Publisher name

Nationwide News Pty. Limited

Place of publication

Darwin

File type

application/pdf

Use

Copyright. Made available by the publisher under licence.

Copyright owner

Nationwide News Pty. Limited

License

https://www.legislation.gov.au/Series/C1968A00063

Parent handle

https://hdl.handle.net/10070/221223

Citation address

https://hdl.handle.net/10070/696707

Page content

NT BUSINESS REVIEW, May, 2010 5 P U B : NTNE-WS-DA-TE:13-GE:105LO-R: C-M Y-K AUSSIE Q RESOURCES $0.405 AQR is a mineral exploration company which holds highly prospective copper/molybdenum projects in the Rawbelle district near the town of Monto in Central Queensland. At the beginning of February, AQR embarked on a new drilling program at the project, Whitewash South, to test the extensions of the mineralised outcropping in an area more than 400m in length and 300m in width. The drilling program of 5000m will test the surrounding areas while slowly making its way towards what is believed to be the bulls eye of the mineralisation. Previous drilling and assay results from last year show the area has the potential to host an exceptionally large mineralised system containing good grades of molybdenum and copper. The company raised $2 million through a placement at 30 cents to institutional and sophisticated investors in February. This leaves the company with a healthy cash balance of $4.6 million on the date of the capital raising, leaving the company in a good position to rapidly advance exploration activities. This shapes to be a very exciting period for Aussie Q Resources. CONNTINENTAL COAL $0.048 Coal is the hot commodity at the moment in the past couple of months, we have seen a number of takeover approaches on Macarthur Coal (MCC) and Gloucester Coal (GCL). So this puts the spotlight on the coal juniors as consolidation within the sector continues. CCC is an emerging international coal producer and explorer with assets in South Africa, with a proven mineable resource of more than 300 million tones within one of the world's largest and most developed mining regions. Mining activities are gaining momentum with the first coal sales from its Vlakvarkfontein coal mine due this month. The company has secured 300,000 tonnes per month of rail allocation for the export thermal coal. It has also secured an off-take agreement with EDF trading, Europe's leading energy provider. The deal provides a $20 million financing package for the development of three mines in return for securing all production of export thermal coal. These funds will be repaid over five years through coal sales with the life of mine expected to be 20 years. Production is expected to generate $150 million in revenue over 20 years. This is a significant off take deal. This is a company with a good story to tell with an excellent portfolio of coal assets and an ambitious production profile. PRIMA BIOMED $0.155 PRR is an Australian biotechnology company focused on fields of cancer immunotherapy and immunology. The company's lead project is the CVac ovarian cancer treatment, the world's first ovarian cancer therapy vaccine. CVac is a maintenance therapy vaccine administered post surgery and post chemotherapy to delay relapse and control metastases. The initial phase 1 and 2a trials of the vaccine were successfully completed with planning and approvals underway for phase 2b and 3 trials. The CVac technology addresses a major global unmet medical need, as there are no maintenance treatments commercially available. Each year 318,000 women are diagnosed with ovarian cancer only 10 per cent survive beyond five years. This technology is designed to significantly increase the survival rate. The global market size of ovarian cancer is estimated to grow to $3.6 billion. This will be a very significant year for PRR as it embarks on final technology trials and aims to achieve several milestones. PRR is well funded with $13.75 million raised from a recent share purchase plan, along with $25.5 million equity funding from a US fund. For any more information on the stocks, call iizen Equities on (08) 8982 2888 05INVESTMENT HOSTING THE WORLD 4 6 fa 0 2 /1 0 LMVD001 Lexus of Darwin 1 Stuart Highway, Darwin Ph: 8946 0000 lexusofdarwin.com.au SETTING NEW STANDARDS IN LUXURY. Overseas model shown Intelligent. Sophisticated. Visionary. The Lexus RX350 takes on the world with an impressive package of standard luxury innovations including Lexus Remote Touch, a revolutionary one-hand command module to control the vehicles ancillaries, 10 SRS airbags, and much more. To experience the ultimate in SUV advancement, test drive the RX350 at your nearest Lexus dealership today. 4 6 fa 0 8 /1 0 Cancer treatment ready for big year Share tips with JAMIE MYERS of iizen Equities FUND FACE: model Alyssa Sutherland heads the ovarian cancer fundraising campaign SURVIVOR: Rosalie Martin won her battle with ovarian cancer with CVac treatment


Aboriginal and Torres Strait Islander people are advised that this website may contain the names, voices and images of people who have died, as well as other culturally sensitive content. Please be aware that some collection items may use outdated phrases or words which reflect the attitude of the creator at the time, and are now considered offensive.

We use temporary cookies on this site to provide functionality.
By continuing to use this site without changing your settings, you consent to our use of cookies.